Disclosure Of First-Time Adoption [Text Block]

Transgene - Filing #6250839

Concept	2024-01-01 to 2024-12-31	As at 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	As at 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	As at 2024-12-31	As at 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31
Disclosure of first-time adoption [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of comparative information prepared under previous GAAP [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity	—	105 760 EUR	—	—	—	—	88 711 EUR	66 147 EUR	—	522,000 EUR	15 203 EUR	446,000 EUR	—	33 971 EUR	—	—	15 612 EUR	83 432 EUR	22 328 EUR	—	—	432,000 EUR	—	71 156 EUR	—	50 426 EUR	—	642,000 EUR	37 841 EUR	50 628 EUR	32 804 EUR	808,000 EUR	450,000 EUR	70 813 EUR	50 102 EUR
Comprehensive income	33 971 EUR	—	- EUR	- EUR	- EUR	- EUR	—	—	33 775 EUR	—	—	—	196,000 EUR	—	22 520 EUR	22 328 EUR	—	—	—	- EUR	- EUR	—	- EUR	—	- EUR	—	192,000 EUR	—	—	—	—	—	—	—	—
Profit (loss)	33 971 EUR	—	- EUR	- EUR	- EUR	- EUR	—	—	33 971 EUR	—	—	—	- EUR	—	22 328 EUR	22 328 EUR	—	—	—	- EUR	- EUR	—	- EUR	—	- EUR	—	- EUR	—	—	—	—	—	—	—	—